| Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy X Li, MT Lewis, J Huang, C Gutierrez, CK Osborne, MF Wu, ... Journal of the National Cancer Institute 100 (9), 672-679, 2008 | 2205 | 2008 |
| Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features CJ Creighton, X Li, M Landis, JM Dixon, VM Neumeister, A Sjolund, ... Proceedings of the National Academy of Sciences 106 (33), 13820-13825, 2009 | 1624 | 2009 |
| Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer MD Burstein, A Tsimelzon, GM Poage, KR Covington, A Contreras, ... Clinical Cancer Research, 2014 | 1311 | 2014 |
| Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer JC Chang, EC Wooten, A Tsimelzon, SG Hilsenbeck, MC Gutierrez, ... The Lancet 362 (9381), 362-369, 2003 | 1064 | 2003 |
| Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer CK Osborne, V Bardou, TA Hopp, GC Chamness, SG Hilsenbeck, ... Journal of the National Cancer Institute 95 (5), 353-361, 2003 | 1040 | 2003 |
| Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes RM Lavinsky, K Jepsen, T Heinzel, J Torchia, TM Mullen, R Schiff, ... Proceedings of the National Academy of Sciences 95 (6), 2920-2925, 1998 | 880 | 1998 |
| BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility Genes DA Berry, ES Iversen Jr, DF Gudbjartsson, EH Hiller, JE Garber, ... Journal of Clinical Oncology 20 (11), 2701-2712, 2002 | 581 | 2002 |
| Medical complications and outcomes after hip fracture repair VA Lawrence, SG Hilsenbeck, H Noveck, RM Poses, JL Carson Archives of internal medicine 162 (18), 2053-2057, 2002 | 553 | 2002 |
| A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models X Zhang, S Claerhout, A Prat, LE Dobrolecki, I Petrovic, Q Lai, MD Landis, ... Cancer research 73 (15), 4885-4897, 2013 | 512 | 2013 |
| p53 is mutated in a subset of advanced-stage prostate cancers R Bookstein, D MacGrogan, SG Hilsenbeck, F Sharkey, DC Allred Cancer research 53 (14), 3369-3373, 1993 | 508 | 1993 |
| Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery VA Lawrence, SG Hilsenbeck, CD Mulrow, R Dhanda, J Sapp, CP Page Journal of general internal medicine 10 (12), 671-678, 1995 | 467 | 1995 |
| Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors DW Parsons, A Roy, Y Yang, T Wang, S Scollon, K Bergstrom, ... JAMA oncology 2 (5), 616-624, 2016 | 458 | 2016 |
| Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. ML Rothenberg, JR Eckardt, JG Kuhn, HA Burris 3rd, J Nelson, ... Journal of Clinical Oncology 14 (4), 1128-1135, 1996 | 458 | 1996 |
| Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer CK Osborne, EB Coronado-Heinsohn, SG Hilsenbeck, BL McCue, ... JNCI: Journal of the National Cancer Institute 87 (10), 746-750, 1995 | 457 | 1995 |
| Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8 ZC Hartman, GM Poage, P den Hollander, A Tsimelzon, J Hill, ... Cancer research 73 (11), 3470-3480, 2013 | 453 | 2013 |
| A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis JD Kessler, KT Kahle, T Sun, KL Meerbrey, MR Schlabach, EM Schmitt, ... Science 335 (6066), 348-353, 2012 | 453 | 2012 |
| Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo AV Lee, JG Jackson, JL Gooch, SG Hilsenbeck, E Coronado-Heinsohn, ... Molecular Endocrinology 13 (5), 787-796, 1999 | 442 | 1999 |
| Risk of pulmonary complications after elective abdominal surgery VA Lawrence, R Dhanda, SG Hilsenbeck, CP Page Chest 110 (3), 744-750, 1996 | 429 | 1996 |
| Identification of tumor-initiating cells in a p53-null mouse model of breast cancer M Zhang, F Behbod, RL Atkinson, MD Landis, F Kittrell, D Edwards, ... Cancer research 68 (12), 4674-4682, 2008 | 392 | 2008 |
| Phase I and pharmacokinetic trial of weekly CPT-11. ML Rothenberg, JG Kuhn, HA Burris 3rd, J Nelson, JR Eckardt, ... Journal of Clinical Oncology 11 (11), 2194-2204, 1993 | 392 | 1993 |
